Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
TENAX THERAPEUTICS, INC.Tenax Therapeutics Reports $15.8 Million Net Loss in Latest Quarter, Increases Focus on Levosimendan
Cenntro Inc.Cenntro Inc. Reports 49.3% Revenue Decline and Increased Losses in Q3 2025
GCT Semiconductor Holding, Inc.GCT Semiconductor Reports 84% Revenue Decline and $13.8 Million Net Loss in Q3 2025
PATRIOT GOLD CORPPatriot Gold Corp. Reports Decreased Net Loss and Zero Revenue for Q3 2025
NATURAL ALTERNATIVES INTERNATIONAL INCNatural Alternatives International Reports 14% Net Sales Increase, Net Loss Reduces
Agassi Sports Entertainment Corp.Agassi Sports Entertainment Reports $755K Net Loss and Seeks Additional Funding
MEDICINOVA INCMediciNova Reports Q3 2025 Revenue of $123,319, Operating Loss of $3.38M
Gores Holdings X, Inc. / CIGores Holdings X Reports $1.84 Million Net Income in Q3 2025 Following IPO
ENTREPRENEUR UNIVERSE BRIGHT GROUPEntrepreneur Universe Bright Group Reports 27% Revenue Decline in Q3 2025
Carisma Therapeutics Inc.Carisma Therapeutics Reports $45.3M in Collaboration Revenues and $44.7M Net Income for Q3 2025
Playboy, Inc.Playboy, Inc. Reports Mixed Financial Results for Q3 and Nine Months of 2025
Kraig Biocraft Laboratories, IncKraig Biocraft Laboratories Reports No Revenue and Increased Losses in Latest Quarter
SurgePays, Inc.SurgePays Reports 291.6% Revenue Growth in Q3 2025, Despite Net Loss
DiaMedica Therapeutics Inc.DiaMedica Therapeutics Reports $8.6 Million Net Loss in Q3 2025
Accelerant HoldingsAccelerant Holdings Reports 74% Revenue Growth and $1.4 Billion Net Loss in Q3 2025
Perimeter Acquisition Corp. IPerimeter Acquisition Corp. I Reports Q3 2025 Financial Results with $2.3M Net Income
Fifth Era Acquisition Corp IFifth Era Acquisition Corp I Reports Net Income of $929,008 for Quarter Ending September 30, 2025
Biofrontera Inc.Biofrontera Inc. Reports Q3 2025 Financial Results with Increased Net Loss
BeyondSpring Inc.BeyondSpring Reports Q3 2025 Financial Results with $4.9 Million Net Loss
Cyclerion Therapeutics, Inc.Cyclerion Therapeutics Reports Q3 2025 Revenue Growth to $875,000 Amid Increased Expenses
Corbus Pharmaceuticals Holdings, Inc.Corbus Pharmaceuticals Reports $23.3 Million Net Loss in Q3 2025, Driven by Increased R&D Expenses
CitroTech Inc.General Enterprise Ventures Reports 169% Revenue Growth but Wider Net Loss in Q3 2025
Cardio Diagnostics Holdings, Inc.Cardio Diagnostics Reports 57% Revenue Decline and Increased Net Losses in Q3 2025
Xenetic Biosciences, Inc.Xenetic Biosciences Reports 67.2% Revenue Growth in Q3 2025, Net Loss Increases
NORTHPOINTE BANCSHARES INCNorthpointe Bancshares Reports Significant Growth with $6.84 Billion in Assets